Clinicopathological features and overexpression of matrix metalloproteinases in intramucosal gastric carcinoma with lymph node metastasis

Clinical Cancer Research

Volumn 6, Issue 9, 2000, Pages 3581-3584

  Kabashima, A ^a   Maehara, Y ^a   Kakeji, Y ^a   Baba, H ^a   Koga, T ^a   Sugimachi, K ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BASEMENT MEMBRANE; CARCINOMA CELL; CONTROLLED STUDY; ENDOSCOPIC SURGERY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH FLOW; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITY OF LIFE; STOMACH CARCINOMA; STOMACH ULCER;

CARCINOMA; FEMALE; GASTRIC MUCOSA; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; STOMACH NEOPLASMS;

EID: 0033813250     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Pathological appearance of the stomach after endoscopical mucosal resection for early gastric cancer
2. Early cancer of stomach
3. Early gastric carcinoma with special reference to macroscopic classification
4. Development of strip-off biopsy (in Japanese, with English abstract)
5. Clinical significance of occult micrometastasis in lymph nodes from patients with early gastric cancer who died of recurrence
6. Metastasizing intramucosal gastric carcinomas
7. Lymph node metastasis in early gastric cancer
8. Clinicopathological features of mucosal carcinoma of the stomach with lymph node metastasis in eleven patients
9. Problems in the definition and treatment of early gastric cancer
10. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer
11. Expression of laminin, collagen IV, fibronectin and type IV collagenase in gastric carcinoma
12. Matrix metalloproteinases
13. Elevated levels of serum and plasma metalloproteinases in patients with gastric cancer
14. Reduced expression of tissue inhibitor of metalloproteinase in nodal metastasis of stomach cancer
15. Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma
16. Expression of interstitial collagenase (matrix metalloproteinase-1) in gastric cancers
17. Plasma concentration of matrix metalloproteinase 9 in gastric cancer
18. Evaluation of endoscopic strip biopsy therapeutically used for early gastric cancer (in Japanese with English abstract)
19. Definition of the adaptation of endoscopic surgery for early gastric cancer: Special examination of the relationship between the histological differentiation of the intramucosal gastric cancer and the lymph node metastasis (in Japanese with English abstract)
20. Endoscopic therapy in patients with inoperable early gastric cancer
21. Lymph node metastasis from early gastric cancer; endoscopic resection of tumour
22. Indication of endoscopic curative resection for early gastric carcinoma from a pathologic point of view (in Japanese with English abstract)
23. Lymph node metastasis from early gastric cancer: Endoscopic resection of tumor
24. Lymph node metastasis in early gastric cancer (in Japanese)
25. Studies on intramucosal carcinoma of the stomach with lymph node metastasis (in Japanese)
26. Clinicopathological study of early gastric cancer (in Japanese)
27. Study on local resection of tumor with preservation of the regional lymph-nodes for early gastric cancer (in Japanese)
28. Indication and limitation of endoscopic treatment for gastric cancer (in Japanese)
29. Lymph and blood capillaries of the human gastric mucosa: A morphologic basis for metastasis in early gastric carcinoma
30. Early gastric carcinoma with special reference to macroscopic classification
31. Immunohistochemical study of MT-MMP tissue status in gastric carcinoma and correlation with survival analyzed by univariate and multivariate analysis
32. Comparison of extracellular matrix-degrading activities between 64-kDa and 90-kDa gelatinases purified in inhibitor-free forms from human schwannoma cells
33. Gelatinases of murine metastatic tumor cells